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The role of endoscopic mucosal resection in gastrointestinal 
precancerous lesions
Gastrointestinal prekanseröz lezyonlarda endoskopik mukozal rezeksiyonun rolü
ÖZ
Amaç: Gastrointestinal maligniteler ve prekanseröz lezyonlarda 
endoskopik mukozal rezeksiyon (EMR) yaygın olarak 
kullanılmaktadır. Bu çalışmada amacımız gastrointestinal 
prekanseröz lezyonların tedavisinde EMR’un etkinliğini 
değerlendirmektir.
Araç ve Gereçler: Binbeşyüz onsekiz hasta retrospektif 
olarak incelendi. Toplamda 59 hastaya EMR uygulandı. Lezyonlar 
20 mm’den büyük ve 20 mm ve küçük olmak üzere 2 gruba ayrıldı. 
Mukozal görünüş ( Kudo pit patern yapısı) ve Paris sınıflamalarına 
göre lezyonlar kaydedildi. Hastalardan iki işlem denemesine 
rağmen polipleri tam çıkarılamayanlar cerrahiye yönlendirildi ve 
bu çalışmaya alınmadı. Yakın takipler esnasında saptanan tekrarlar 
kaydedildi.
Bulgular: Elli dokuz hastadan toplam 94 polip rezeke 
edildi. Hastaların 42 ( %71,2)’ sine enblok, 17 (%28,8 )’sine 
ise piecemeal rezeksiyon uygulandı. İki yöntem arasında yaş, 
cinsiyet, histopatoloji, komplikasyonlar, tekrar ve makroskobik 
tipler açısından farklılık gözlenmedi (P>0,05). 20 mm’den büyük 
poliplerde Kudo tip 4 görünüş ve adenomatöz polipler (P=0,001) 
yaygın olarak izlendi (P=0,03).
Sonuçlar: Prekanseröz lezyonlarda EMR işlemi düşük 
komplikasyon ve kabul edilebilir tekrar oranları ile güvenli 
ve kullanışlı bir işlemdir. Kudo pit patern yapısı kanser riski 
değerlendirilmesinde rutin olarak kullanılmalıdır.
Anahtar kelimeler: Endoskopik mukozal rezeksiyon, 
Gastrointestinal prekanseröz lezyon, Pit paterni, Nüks
Introduction
The use of endoscopic mucosal resection (EMR) was 
pioneered in Japan for the treatment of early gastric 
cancer and has been widely used in treating other early 
gastrointestinal malignancies and precancerous lesions [1-
4].
Early endoscopic detection and removal of 
gastrointestinal precancerous lesions reduce the incidence of 
ABSTRACT
Objectives: Endoscopic mucosal resection (EMR) has 
been widely used in early gastrointestinal malignancies and 
precancerous lesions. We aim to analyze the outcomes of EMR for 
gastrointestinal precancerous lesions.
Materials and Methods: A total of 1,518 cases were 
retrospectively analyzed. Of these, 59 patients had undergone 
EMR for gastrointestinal lesions. The lesions were divided into 
two subgroups according to size; smaller than 20 mm and equal or 
larger than 20 mm. The mucosal aspect (Kudo pit pattern), Paris 
classification of the resected lesions and recurrences that were 
determined during close follow-up were recorded.
Results: A total of 94 polyps were resected in 59 patients. 
En-block resection was performed in 42 (71.2%) patients and 
piecemeal resection in 17 (28.8%). There was no significant 
difference between two modalities; regarding age, gender, 
histopathology, complications, recurrence or macroscopic type 
(P>0.05). However, the occurrence of Kudo type 4 lesions and 
adenomatous polyps (P=0.001) was significant in the >20 mm 
group (P=0.03).
Conclusion: Endoscopic mucosal resection is a safe and 
feasible procedure for precancerous lesions, with low complication 
and acceptable recurrence rates. Additionally, the Kudo pit pattern 
should be taken into consideration on a routine basis when 
determining the risk of cancer.
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gastrointestinal malign neoplasias [5]. It has recently been 
shown that colonoscopic polypectomy significantly reduces 
the incidence of colorectal cancer associated with mortality 
[6]. Cancer screening programs, which are currently 
broadly implemented, can facilitate the detection of cancers 
at a curable stage, also help to diagnose more precancerous 
lesions. The increase in the detection of precancerous 
lesions, brings with it the need for more treatment facilities 
and optimal treatment techniques to facilitate cost-effective 
care. Endoscopic treatment of gastrointestinal precancerous 
lesions may prevent the need for surgical interventions such 
as segmental resection, wedge resection, hemicolectomy, 
eosophagectomy and gastrectomy with their associated 
complications. The resection of polyps can be performed 
en-bloc or piecemeal, according to the size and location 
of the lesion. Large adenomas require treatment beyond 
simple loop polypectomies or single-piece EMR, with the 
piecemeal method being the most common endoscopic 
resection technique used for them. However, piecemeal 
resection often leads to high rates of residual adenoma 
found during the follow-up period [7]. Two recently 
published prospective studies on the piecemeal EMR of 
colorectal adenomas, report residual adenoma rates as 20–
38%, although, late recurrence was eventually diagnosed in 
less than 5% of these patients [8,9]. A previous systematic 
review, including 20 studies on EMR of large (>2cm) 
colorectal adenomas, described an early recurrence rate of 
11.2% (after a single attempt), where the lesions were in fact 
residual adenomas rather than actual recurrences. If those 
adenoma remnants were re-treated within 6 months, the late 
recurrence rate then dropped to 1.5% and complication rates 
were 3.8% [10].
In many countries, EMR is considered a complex 
endoscopic procedure and is usually only performed at 
specific centers to preserve its effectiveness and safety [11]. 
However, the complication rate associated with EMR is low 
[12]; the most frequent adverse effect is bleeding [13-17], 
followed by perforation [3,18,19], as well as recurrence [15-
17,20]. Consequently, the use of EMR for gastrointestinal 
precancerous lesions has become increasingly popular 
in Western countries and has been found to be a safe 
and efficient treatment. This technique is not commonly 
practiced in rural hospitals in Turkey and most reports come 
from large tertiary referral practices. The aim of this present 
study is to retrospectively analyse the outcomes of EMR for 
gastrointestinal precancerous lesions with a particular focus 
on procedural complications and recurrence rates in two 
centers in Turkey.
Material and Methods
After being approved by the ethical board of Istanbul 
Medeniyet University, Göztepe Research and Training 
Hospital (2015/0140), a total of 1,518 patients who were 
referred to Istanbul Medeniyet University, Göztepe Research 
and Training Hospital and Istanbul Gastroenterology Centers 
for upper and lower gastrointestinal endoscopy between 
January 2011 and January 2015, were retrospectively 
analyzed. Only those patients with lesions suitable for EMR 
were included in the study. EMR procedures were performed 
on 59 patients by two endoscopists. Before the EMR, Kudo 
pit pattern type and Paris classification of all lesions were 
recorded [21,22]. Lesion size was endoscopically estimated 
using open biopsy forceps or a resection snare, although as 
some lesions were resected using the piecemeal method, an 
accurate size could not be calculated. Lesions were divided 
into two subgroups: those smaller than 20mm (<20mm) 
and those equal/larger than 20mm (≥20mm). Patients were 
excluded from the study if the mucosa was non-lifting or 
if there was any suspicion of submucosal invasion during 
diagnostic medical tests including computed tomography, 
magnetic resonance imaging or endoscopic ultrasonography. 
Patients that fulfilled all criteria were advised to undergo 
endoscopic treatment, additionally routine informed 
consents were obtained before each procedure.
Resection method
Before the endoscopic procedure, a split dose bowel 
preparation was used for the lower gastrointestinal area. 
Anticoagulant therapy was normally discontinued three 
days prior to the procedure. At the endoscopist’s discretion, 
either conscious or deep sedation was administered using 
midazolam or propofol. Diagnostic endoscopes such as 
GIF-H180 or GIFHQ180: Olympus, Tokyo, Japan and 
VP4400 with XL 4400: Fujinon, Tokyo, Japan were preferred 
for the procedure. EMR was performed with polypectomy 
snares. Standard large (30mm: Boston Scientific, Natick, 
Massachusetts, USA); barbed (20mm: Olympus, Tokyo, 
Japan); or standard small (13 mm: Boston Scientific, Natick, 
Massachusetts, USA) snares were used in the piecemeal 
resection type. After proper endoscopic visualization of 
a lesion, it was lifted by injecting a large volume (10-100 
mL) of a pre-mixed solution submucosally, using a saline 
solution of 0.9%, 1mL methylene blue and 1:10,000 units 
of adrenaline. Lesion margins were not routinely marked 
with mucosal cautery. The open snare was placed around 
the lesion and was gently pressed against the mucosa. The 
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aim was to resect the lesions in one single piece rather than 
piecemeal, if possible. After the snare excision, air was 
insufflated to visualize the area of resection and, if needed, 
any further residual tissue was removed with a similar 
technique. Snare resection was continued until the lesion 
was macroscopically entirely removed, and the blue colored 
submucosa was visible. The settings used were “auto-cut” 
at a set power of 120 W, along with the “endo-cut” mode. 
After resection, adjuvant heater probe coagulation therapy 
was used to remove any tiny visible remnants of lesions. 
There was no prophylactic treatment of visible vessels in 
the EMR defect; that were not bleeding and polypectomy 
sites were not closed with clips. Patients were discharged 
after the procedure.
Histopathological evaluation
After retrieval, whenever possible the size of the lesions was 
estimated by comparison and using open biopsy forceps. 
All removed tissue was retrieved using a retrieval basket, 
grasper or through the suction channel. All retrieved lesions 
were examined and classified by several experienced 
pathologists at the respective histopathology departments 
of each center. Polyps were classified as adenoma, 
intramucosal carcinoma or non-adenoma (e.g. hyperplastic 
polyps, leiomyoma, neuroendocrine tumour, lipoma, gastric 
mucosa). Adenomas were further classified for grade of 
dysplasia (i.e. low, or high-grade) using a combination of 
variables, including tubule configuration, nuclear polarity, 
orientation and structure, mucin content and location, 
etc, according to the Konishi-Morson system. [23]. The 
diagnosis of intramucosal carcinoma included adenomas 
with neoplastic cells invading the lamina propria mucosa 
[24,25]. It was impossible to evaluate the resection margins 
in piecemeal resection specimens;thus, only the basal 
margins, lesion type, and degree of dysplasia were assessed 
in these cases. When submucosally invasive carcinoma 
was diagnosed in the resection specimen, the necessity for 
additional treatment was discussed by a multidisciplinary 
team, and the patient was excluded from the study.
Follow-up and recurrence
Surveillance endoscopies were performed at various intervals 
of the follow up period. All patients underwent repeat 
endoscopies 3 months later and surveillance endoscopies 
were scheduled at 6, 12, 24 and 36 months after EMR. 
During endoscopic follow-up, any alterations in the mucosa 
of the resection area (scarring, retractions of mucosa, etc.) 
were biopsied. If the scar appeared visibly normal, without 
the presence of adenomatous tissue, random biopsies were 
taken from its center and its edges. Recurrence was defined 
as the presence of adenomatous or polypoid tissue in a 
single follow-up endoscopy. All remnants and recurrences 
were treated endoscopically, if practical.
Statistical analysis
Data analysis was performed using Number Cruncher 
Statistical System (NCSS) 2007 (NCSS, LLC Kaysville, 
Utah, USA). Descriptive statistics for continuous 
variables were shown as mean ± standard deviation or 
median (minimum-maximum), and categorical variables 
were shown as both the number and percentage of cases. 
Significant differences between the groups; in terms of mean 
value were analyzed with Student’s t-test while median 
value differences were analyzed with the Mann-Whitney U 
test. Categorical variables were assessed by Pearson’s chi-
square test, Fisher’s Exact test and Fisher Freeman Halton 
test. A P value less than 0.05 was considered statistically 
significant.
Results
In total, 94 polyps in 59 patients were treated. Of these, 
30 polyps were large gastrointestinal precancerous lesions 
(mean diameter >20mm) with 19 patients having more 
than one lesion. 55 patients (76.3%) had lesions localized 
in the colon and rectum area; 14 patients (23.7%) had 
lesions in the stomach. En block resection was performed 
in 42 (71.2%) patients; piecemeal resection in 17 (28.8%). 
Macroscopically, lesions were protruding in 47 patients 
(79.7%), superficial in 8 patients (13.6%), and lateral 
spreading in the remaining 4 patients (6.8%). According 
to Paris classification grading, 1p, 1s and 2a grades were 
seen in 50 (84.7%), 8 (13.6%), and 1 patients (1.7%), 
respectively. Kudo pit patterns were as follows: type 4 - 
24 patients (39.0%); 3L - 21 patients (35.6%); 2 out of 11 
patients (18.6%) had type 2; and 4 patients (6.8%) had 3S. 
The characteristics of the patient population, including the 
polyp size and location, are presented in Table I. Complete 
resection was achieved in 56 patients (95%) while incomplete 
polyp resection in 3 patients required repeated sessions. One 
patient had significant bleeding during polypectomy and 
after no response to hemostatic interventions, underwent 
right hemicolectomy.
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Table I: Demographics and clinical characteristics 
Age (years), 62.54±12.31 
Duration of process (min) 13 (2-66)  
 n % 
Gender   
 Male 24 40.7 Female 35 59.3 
Pathology   
 Non-adenomatous 16 27.1 
Adenomatous 43 72.9 
Type of adenomatous polyp   
Tubular Adenoma 17 39.5 
Tubulovillous Adenoma 20 46.5 
Villous Adenoma 6 14.0 
Localization   
 
Stomach 16 27.1 
Colon 28 47.5 
Rectum 15 25.4 
Complication 1 1.7 
Recurrence 2 3.4 
Dimension of lesion   
 < 20 mm 29 49.2 ≥20 mm 30 50.8 
Macroscopy   
 
Superficial 8 13.6 
Protruding 47 79.7 
Lateral Spreading Type 4 6.8 
Technique    
 En-block 42 71.2 Piecemeal 17 28.8 
Paris classification   
 
1p 50 84.7 
1s 8 13.6 
2a 1 1.7 
Kudo classification   
 
2 11 18.6 
3L 21 35.6 
3S 4 6.8 
4 23 39.0 
 
The median follow-up period was 12 months (6-36 
months). Local recurrence was recorded in two patients 
(3.4%), at the sixth month with a histopathological pattern 
of low-grade displasia. Remnant adenomatous tissue was 
found during follow-up in 2 of the 59 patients (3.4%).
Adenomatous polyps were found in thirty-seven patients 
(62.7%) with low-grade dysplasia in 26 patients (44.1%), 
and high-grade dysplasia in the remaining 11 (18.6%). There 
were twenty-two patients (27.3%) with non-adenomateous 
polyps: these comprised 11 (18.6%) hyperplastic polyps; 
6 (10.2%) intramucosal cancers; 2 (3.4%) regular gastric 
mucosa; 1 (1.7%) neuroendocrine tumor; 1 (1.7%) 
leiomyom and 1 (1.7%) lipom.
Age, gender, histopathology, complications, recurrence 
or macroscopic type were not predictive values for the 
adoption of en-block or piecemeal resection (P>0.05). 
96 Orman and Gultekin
EMR for gastrointestinal precancerous lesions Marmara Medical Journal 2017; 30: 92-100
However, en-block resection was more frequently used 
for lesions of the stomach, whereas piecemeal resection 
was associated with rectal lesions (P=0.042). Piecemeal 
resection usage was also significantly higher in lesions 
≥20mm (P=0.001), (Table II), and the duration of this 
procedure was significantly longer (P=0.001).
No significant difference was found between en-block 
and piecemeal resection according to Paris and Kudo 
classifications (P>0.05), (Table III).
The prevalence of Kudo type 4 lesions and adenomatous 
polyps (P=0.001) was significantly associated with lesions 
≥20mm (P=0.03). Kudo type 2 lesions were more frequent 
in the stomach with type 4 lesions more common in the 
rectum (P=0.001), but the distribution of colonic lesions 
according to Kudo types was not significantly different 
(P>0.05). Meanwhile, a significant association was found 
between the subgroups of adenomatous polyps and their 
Kudo classification type (P=0.02), (Table IV).
Table II: Comparison of the techniques 
 En-block (n=42) Piecemeal (n=17) P 
Gender   a0.088 
 
Male 20 (47.6) 4 (23.5) 
 
Female 22 (52.4) 13 (76.5) 
Age (years) 62.79±12.93 61.94±10.98 b0.814 
Pathology   d0.115 
 
Non-adenomatous 14 (33.3) 2 (11.8) 
 
Adenomatous 28 (66.7) 15 (88.2) 
Localization   e0.042 
   
Stomach 14 (33.3) 2 (11.7) 
 Colon 21 (50.0) 7 (41.2) 
Rektum 7 (16.7) 8 (47.1) 
Complication   d1.00 
 
Yes 1 (2.4) 0 
 
No 41 (97.6) 17 (100.0) 
Recurrence   d1.00 
 
Yes 2 (4.8) 0 
 
No 40 (95.2) 17 (100.0) 
Dimension of lesion   a0.001 
 
< 20 mm 29 (69.0) 0 
 
≥ 20 mm 13 (31.0) 17 (100.0) 
Duration of process (min) 2-45 (10.5) 3-66 (22) c0.001 
Macroscopy   e0.127 
 
Superficial 6 (14.3) 2 (11.8) 
 Protrude 35 (83.3) 12 (70.6) 
Lateral Spreading Type 1 (2.4) 3 (17.6) 
aPearson Chi-Square Test, bStudent T Test, cMann-Whitney U Test, dFisher Exact Test  
eFisher Freeman Halton Test,  
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Discussion
Several studies have been published regarding the safety 
and therapeutic potential of the endoscopic resection of 
gastrointestinal precancerous lesions. The most frequently 
reported adverse complication of EMR is bleeding, occurring 
in 1% to 45% of all cases [13-17] and the perforation rate 
has been reported as between 0.7% and 4% [3,18,19]. Our 
complication rate (intraprocedural bleeding) in this present 
study was 1.7%. Generally, complication rates of EMR 
are lower than those who undergo open surgery (2.3% to 
6.3%) and comparable to those undergoing laparoscopic 
surgery (1.9% to 6.9%) [26]. Moreover, mean hospital stay 
for the patients who undergo colorectal surgery is 9.2-13.2 
days and gastric surgery is 5.9-12.1 days, both significantly 
longer than EMR procedures which are usually performed 
as day cases [26,27]. Therefore, EMR is a good alternative 
to surgery in selected patients, especially as all lesions can 
frequently be removed in a single session, eliminating the 
discomfort for patients of repeated procedure. This was 
achieved in 95% of resections in the present study.
En-block resection is usually preferred to piecemeal 
resection, because it provides more accurate histological 
assessment and reduces the risk of local recurrence [28]. 
However, in the present study there were two recurrences 
(3.4%), with no significant difference found in the 
recurrence rate data between the two resection techniques 
used. Clearly, follow-up is essential due to the risk of 
recurrence; aggressive monitoring seems justified, as animal 
research has shown that residual tumor has a high re-growth 
rate [29]. All patients in the present study had follow-up 
upper and lower gastrointestinal endoscopy. A wide range 
of recurrence rates after EMR of colorectal polyps and 
gastric polyps has been previously reported: between 0% 
and 46% [15-17,30,20]. In the present study, our recurrence 
rate was 3.4% for gastrointestinal precancerous lesions. 
Several studies have suggested that the size of polyps is 
associated with recurrence [31-34]; however, no relation 
was found in the present study, suggesting that EMR can 
be carried out safely and effectively for gastrointestinal 
precancerous lesions. However, strict follow-up may be 
required for histologically advanced lesions due to a higher 
risk of recurrence.
This two-center study provides a faithful reflection of 
current daily practice in Turkey. Subsequent endoscopic 
follow up and treatment of adenoma remnants was possible 
in 100% of the patients. The recurrence and complication 
rates in our study compared favorably with previously 
published data on large gastrointestinal EMRs. Moss et al. 
demonstrated the feasibility of piecemeal EMR in colorectal 
adenomas, reporting very high case-volumes in a multicenter 
collaboration. Their results (early recurrence rate 20.4%; 
morbidity 7.7%) have established a sound standard for 
future endoscopists pursuing similar proficiency [9].
According to a recent study by Buchner et al., larger 
polyp size and the piecemeal nature of the resection were 
independent predictors of recurrence and complication 
[8]. In our study, we had just two recurrences and tumor 
size was not predictive of any recurrence or complication. 
This could be related to the prevalence of small sized 
lesions compared to large sized lesions and more frequent 
20 
 
Table III. Comparison of techniques according to Paris and Kudo classifications 
 En-block (n=42) Piecemeal (n=17) P 
Paris classification   e0.768
 
1p 36 (85.7) 14 (82.4) 
1s 5 (11.9) 3 (17.6) 
2a 1 (2.4) 0 
Kudo classification   e0.096
 
2 9 (21.4) 2 (11.8) 
3L 18 (42.9) 3 (17.6) 
3S 2 (4.8) 2 (11.8) 
4 13 (31.0) 10 (58.8) 
eFisher Freeman Halton Test 
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en-block resections. Non-adherence to protocols regarding 
the use of argon plasma coagulation (APC) has influenced 
recurrence rates in some studies; and previous studies have 
shown contradictory results regarding the effects of APC on 
adenoma recurrence [9,35]. In our study, a heater probe was 
used for the residue lesion areas.
Remnant or recurrent adenomatous tissue may be 
present as dysplasia in random biopsies of an apparently 
healed mucosectomy scar. This may be explained by the 
fact that chromoendoscopy or virtual chromoendoscopy-
like narrow band imaging are not routinely used for the 
detection of dysplastic lesions located in the scar. Moreover, 
in the 2 recurrences we detected, the adenomatous tissue 
might well have been missed during the prior endoscopy 
due to insufficient imaging, poor bowel preparation or 
localization behind a fold. Undoubtedly, strict monitoring 
with high quality endoscopes is essential in the follow-up 
period of these patients.
Moreover, overall success of the total intervention 
strategy, including endoscopic surveillance and concurrent 
treatment of recurrence, can rectify a relatively high 
recurrence rate. Our two patients, whose remnant or 
recurrent adenomas were treated endoscopically, were 
free of recurrence in further monitoring endoscopies. All 
recurrences were low-grade displasia and no invasive 
cancers were detected during follow-up endoscopies.
Polyp morphology and the mucosal aspect may be 
predictive of submucosal invasion. Moss et al. identified 
the Paris 0-IIa+c classification as a risk factor, especially 
in combination with nongranular surface morphology [7]. 
However, none of the lesions included in the present study 
was classified as IIa+c. The mucosal aspect (Kudo pit 
pattern) of the resected adenoma is routinely assessed and 
defined for all our lesions. This may reflect the familiarity 
of endoscopists with dedicated classification systems such 
as the Kudo pit pattern type. Hence, endoscopists, especially 
21 
 
Table IV. Association of Kudo classification with lesion characters  
 Kudo classification P 
 2 3L 3S 4 
 
Dimension     *0.030 
 
<20 mm 7  14  2  6  
 
 
≥20 mm 4  7  2  17  
Localization     0.001 
 
Stomach 7  8 1  -  
 
 Colon 3  9  3  13  
Rectum 1  4  - 10  
Pathology     0.001 
 
Adenomatous 4  14  3  22   
 
Non-adenoma 7  7 1  1  
Type of polyp     0.022 
 
Tubular Adenoma 4  8  - 5   
 
 Tubulovillous Adenoma 0 4  2  14  
Villous Adenoma 0 2  1  3  
Paris classification     0.020 
 
1p 10  19  1  20   
 
1s 1  1  3  3  
2a - 1 - - 
*Fisher Freeman Halton Test 
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those resecting gastrointestinal precancerous lesions, should 
receive proper training in endoscopic pattern recognition.
In the present study, the small size sample and its 
retrospective nature present limitations. On the other hand, 
the predictive value of the Kudo classification, particularly 
Kudo type 4, in determining adenomatous polyps and 
cancer risk was analyzed in detail. Also, in contrast to other 
studies, besides adenomatous polyps, nonadenomatous 
precancerous lesions such as neuroendocrin tumors and 
leiomyoms were also analyzed.
In conclusion, we believe EMR to be a safe and feasible 
procedure for precancerous lesions, with low complication 
and acceptable recurrence rates. Clearly, the Kudo pit 
pattern should be considered in assessing cancer risk. Our 
low recurrence and complication rates also emphasize 
the importance of training and centralization of this 
procedure;optimal diagnostic work-up, the possibility of 
missed remnants, and recurrences during follow-up support 
this recommendation.
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